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Abstract
Background: Leukocyte Ig-like receptors (LILR) are a family of innate immune receptors with
immunomodulatory functions. High-level expression of the receptors LILRB2 (ILT4) and LILRB4
(ILT3) is a feature of tolerogenic antigen presenting cells and has been observed in cancer and
transplant situations. There are relatively few studies regarding these receptors in the context of
infection and it is not yet clear how LILRB4 exerts its inhibitory effects.
Results: We studied the effects of LILRB4 ligation on antigen presenting cell phenotype, and the
expression of LILRB2 and LILRB4 on Salmonella-infected antigen presenting cells. Ligation of LILRB4
throughout in vitro culture of dendritic cells led to an upregulation of the co-stimulatory protein
CD86. Alterations in the production of IL-8 and IL-10 by LILRB4-ligated macrophages were also
observed. Infection with Salmonella typhimurium or TLR stimulation with Salmonella components led
to an upregulation of LILRB2 and LILRB4.
Conclusion: Our results indicate that the inhibitory effects of LILRB4 do not result from a failure
to upregulate co-stimulatory proteins. In addition to the high level expression that can render
antigen presenting cells tolerogenic, there may be a role for lower level expression and activity of
LILRB2 and LILRB4 in response to TLR signalling during an immune response to bacterial infection.
Background
Leukocyte Ig-like receptors (LILR, also known as ILT and
LIR) are a family of innate immune receptors that are pre-
dominantly expressed on cells of the myelomonocytic lin-
eage [1]. The 11 members of the LILR protein family are
divided into 'activating' (subfamily A) or 'inhibitory' (sub-
family B) receptors on the basis of their transmembrane
and cytoplasmic domains. There is a growing interest in
LILR expression and/or function in situations of immune
dysregulation and following transplantation [2-4], but as
innate immune receptors they would also be predicted to
play a role in an immune response to infection.
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expressed on myeloid antigen presenting cells which asso-
ciates with the protein tyrosine phosphotase SHP-1 [5].
The importance of this particular receptor as an immune
modulator was highlighted when it was shown that high
level expression of LILRB4 with LILRB2 rendered antigen
presenting cells tolerogenic [4,6,7]. LILRB4 and LILRB2
may differ in their mechanisms of immune regulation. In
receptor ligation studies, the tolerogenic properties of
LILRB2 appear to result from phenotypic changes to the
antigen presenting cells that express them, including fail-
ure to upregulate co-stimulatory proteins and MHC class
II [8,9]. In contrast, although no receptor ligation studies
have been performed for LILRB4 on antigen presenting
cells, at least some of its inhibitory effects may result from
reverse signalling through its T cell ligand, as soluble
forms of LILRB4 have been shown to suppress T cell
responses [10,11]. LILRB4 ligation was therefore per-
formed to determine the phenotypic effects of receptor
engagement on antigen presenting cell phenotype.
Given their potential to inhibit T cell proliferation,
LILRB2 and LILRB4 have been studied in the context of
allograft tolerance during transplantation and during can-
cer [4,10,12,13]. The ability of LILRB2 and LILRB4 to
modulate T cell responses could also be of relevance dur-
ing infection, where skewing of LILRB4 and/or LILRB2
expression might alter the course of an immune response.
To better understand the inhibitory potential of LILRB2
and LILRB4 during pathogenic challenge, we set out to
determine how their expression is modulated on antigen
presenting cells infected with Salmonella typhimurium, as
this obligate intracellular pathogen infects macrophages.
Results
Cell surface phenotype and T cell stimulatory capacity of 
LILRB4-ligated dendritic cells
Flow cytometric analysis of cell surface markers was used
to determine the effects of LILRB4 ligation on the cell-sur-
face phenotype of antigen presenting cells cultured in
vitro. This technique has been used successfully for studies
of other LILR family members [8,14,15]. Cells were cul-
tured with a LILRB4-specific antibody (ZM3.8) and
crosslinking agent (protein G), both replenished through-
out culture in order to maintain receptor crosslinking.
Ligation with ZM3.8 triggers LILRB4 activation and SHP-
1 recruitment [5]. Ligation of LILRB4 led to an upregula-
tion of the co-stimulatory protein CD86 on dendritic cells
on both immature and LPS-matured dendritic cells (Fig-
ure 1). No significant effects on the expression of CD1a,
CD80 or CD83 were observed.
We also tested whether ligation of LILRB4 resulted in any
cell-surface changes that might inhibit the ability of den-
dritic cells to stimulate naïve CD4+ T cells. Mixed leuko-
cyte reactions (MLR) were performed using naïve CD4+ T
cells isolated from allogeneic subjects. Results of five MLR
experiments indicated no consistent increase or decrease
in T cell proliferation in response to LILRB4 cross-linked
dendritic cells (Figure 2).
LILRB4 ligation alters the cytokine secretion profile of 
macrophages
We then examined the effects of LILRB4 ligation on
cytokine secretion by antigen presenting cells. Superna-
tants were harvested from in vitro macrophage cultures.
During an initial screen by cytokine bead array (CBA), dif-
ferences in IL-8 and IL-10 production were observed.
These changes were further analysed by ELISA. Although
results were not statistically significant by two-sided Stu-
dent's t test, the concentration of IL-8 in culture superna-
tant was seen to be decreased following LILRB4 ligation
for both immature and LPS-matured cells (Figure 3). In
contrast, LILRB4 cross-linking increased levels of IL-10 in
the culture supernatant.
Salmonella typhimurium infection upregulates 
expression of LILRB2 and LILRB4
To investigate the biology of LILRB2 and LILRB4 on anti-
gen presenting cells in the context of infection, we
infected monocyte-derived macrophages with Salmonella
typhimurium transformed with the pFVP25.1-GFP plasmid
[16]. Infection of macrophages was confirmed by GFP
expression as assessed by flow cytometry. Real-time PCR
analysis showed upregulation of both LILRB2 and LILRB4
in Salmonella-infected macrophages (Figure 4). A similar
result was observed when macrophages were treated with
heat-killed bacteria (Figure 5).
We then investigated whether bacterial components
known to trigger Toll-like receptors (TLR) could elicit a
similar response. Recognition of lipopolysaccharide (LPS)
is predominantly mediated by TLR4 [17,18], and flagellin,
a potent innate immune stimulator is recognised by TLR5
[19]. Treatment of in vitro-cultured macrophages with Sal-
monella typhimurium LPS led to an increase in LILRB2 and
LILRB4 in our real-time PCR assay, similar to that
observed for whole Salmonella. Upregulation was less pro-
nounced for cells treated with flagellin (Figure 5). TLR
stimulation was also performed on in vitro-cultured den-
dritic cells, with a general upregulation of LILRB2 and
LILRB4 observed following LPS stimulation, and little or
no effect for flagellin treatment (Figure 6).
Discussion
We have shown that continuous ligation of LILRB4 during
in vitro culture of dendritic cells led to an enhanced upreg-
ulation of CD86. This contrasts with LILRB2, where liga-
tion results in a failure to upregulate costimulatory
proteins including CD86 [8,9]. A mixed leukocyte reac-Page 2 of 9
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not result in any changes to the surface phenotype of anti-
gen presenting cells that could inhibit T cell proliferation.
Our results complement previous work from Suciu-Foca et
al, which has shown that a soluble form of LILRB4 is suf-
ficient to inhibit T cell stimulation [10,11]. Thus,
although they have similar expression profiles and similar
effects on T cell proliferation, LILRB2 and LILRB4 may use
different modes of action to regulate T cell activity - with
LILRB2 limiting the co-stimulatory potential of antigen
presenting cells whilst LILRB4 acts through its T cell lig-
and, during T cell/antigen presenting cell contact.
Although limited effects on the surface phenotype of anti-
gen presenting cells were observed in our study, LILRB4
cross-linking did result in some alteration of cytokine
secretion profile. LILRB4 ligation led to an upregulation
of IL-10 secretion by in vitro-cultured macrophages. This
inhibitory cytokine may contribute to a feedback loop of
LILR-mediated inhibition as it upregulates LILRB1,
LILRB2, LILRB3 and LILRB4 on antigen presenting cells
[20-22]. IL-8 is an inflammatory chemokine that attracts
cells of the innate immune system [23]. That LILRB4-liga-
tion results in increased production of IL-10, a potently
anti-inflammatory factor [24], and correspondingly
reduces expression of the strongly inflammatory IL-8, is
consistent with its immune inhibitory nature.
The interaction between professional antigen presenting
cells and antigen-specific T cells provides signals impor-
tant for the efficient activation and maintenance of a T cell
response but also, as evidenced by our receptor-ligation
Cell surface phenotype of LILRB4-ligated dendritic cellsFigure 1
Cell surface phenotype of LILRB4-ligated dendritic cells. Flow cytometric analysis of cell surface markers was per-
formed for dendritic cells cultured in the presence of an isotype control antibody (Isotype) or LILRB4-specific antibody 
(LILRB4) with Protein G. LPS-matured dendritic cells cultured in the presence of isotype control antibody (Isotype+LPS) or 
LILRB4-specific antibody (LILRB4+LPS) were also compared. Results for individual donors are indicated by joined lines. A min-
imum of 5 individuals were examined for each marker. Statistical analysis of isotype control versus LILRB4-ligated cells was 
performed using a Wilcoxon matched pairs test on Prism Software (GraphPad, USA).Page 3 of 9
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T cell stimulatory properties of LILRB4-ligated dendritic cellsFigure 2
T cell stimulatory properties of LILRB4-ligated dendritic cells. B. Dendritic cells were cultured in the presence of iso-
type control or LILRB4-specific antibody with cross-linking and LPS matured as before. Naïve CD4+ T cells from an allogeneic 
donor were added at various stimulator:responder (S:R) ratios and cultured for 6 days. CD4+ T cell proliferation was assessed 
by thymidine incorporation. Triplicate wells were analysed with error bars representing the SEM. Results are shown for 2 
experiments, which are representative of the 5 performed.
LILRB4 ligation throughout macrophage culture reduces IL-8 but increases IL-10 productionFigure 3
LILRB4 ligation throughout macrophage culture reduces IL-8 but increases IL-10 production. Cytokine levels in 
supernatants of in vitro-cultured macrophages were analysed by ELISA. Macrophages were cultured in the presence of Isotype 
control or LILRB4 specific antibody. Three sets of triplicate samples were analysed with error bars representing the SEM. Sta-
tistical testing by two-sided Student's t test did not show any significant differences between treatment groups.
BMC Immunology 2009, 10:56 http://www.biomedcentral.com/1471-2172/10/56studies, provides signals important for regulation of
inflammation. We propose that LILRB4 plays a dual
immunoregulatory role to limit both innate and adaptive
immunity; cell-cell contact would allow LILRB4 on the
antigen presenting cell to deliver an inhibitory signal to T
cells to regulating adaptive immunity whilst delivering an
inhibitory signal to innate immune cells through
decreased IL-8.
Although we saw no effect of LILRB4 cross-linked antigen
presenting cells on the quantity of T cell proliferation, it is
possible that there may have been qualitative differences
in the T cell cultures. Further studies would be necessary
to determine whether culture with LILRB4-crosslinked
antigen presenting cells leads to alterations in T cell func-
tion or the ratio of, for example, regulatory or suppressor
subsets.
The rapidly growing field of LILR biology has begun to
address the expression and relevance of these receptors
during immune dysregulation or transplant situations,
but there is relatively little knowledge regarding LILR dur-
ing infection. To address this, we observed the effects of
Salmonella infection on LILRB2 and LILRB4 expression.
Infection of macrophages with Salmonella resulted in an
upregulation of LILRB2 and LILRB4. Similar effects were
observed when cells were treated with heat-killed Salmo-
nella or Salmonella LPS, which might indicate that the
Salmonella typhimurium upregulates expression of LILRB2 and LILRB4 on in vitro-cultured macrophagesFigure 4
Salmonella typhimurium upregulates expression of LILRB2 and LILRB4 on in vitro-cultured macrophages. Real-
time PCR was used to assess the expression of LILRB2 and LILRB4 mRNA in monocyte-derived macrophages treated with 
either live or heat-killed GFP+ S. typhimurium. Salmonella infection was confirmed by flow cytometic detection of GFP (data not 
shown). p-values were calculated using a two-tailed Wilcoxon rank test, using a 95% confidence level on Prism Software 
(GraphPad, USA).Page 5 of 9
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largely due to LPS recognition. The effects of LILR and TLR
signalling on each other's expression and function is likely
to be a future topic of interest in the field of innate/adap-
tive immune regulation; both families are predominantly
expressed on the same cell types, LILR activity can inhibit
TLR function [3,25], and TLR triggering can modulate
LILR expression [26]. The relationship between TLR
(innate immune receptors for microbes) and LILR (innate
immune receptors for self) may therefore represent an
immunostimulatory/immunoregulatory balance, with
inhibitory LILR upregulation acting as a mechanism to
prevent an over-exuberant immune response.
Antigen presenting cells show versatility in their ability to
tailor an immune response specific to individual classes of
pathogens. Variations in LILR expression profile, with
their effects on surface phenotype and cytokine secretion,
could help skew immune responses in different direc-
tions. Our experiments, and those of Cohen et al using
Porphyromonas gingivalis show an upregulation of LILRB4
in response to LPS treatment [27], but stimulation with
TLR9 ligands led to a downregulation of LILRB4 [26]. It is
also notable that in microarray analysis for Salmonella
typhimurium lacking a virulence factor that can promote
LPS modification, LILRB4 was one of the few genes whose
expression was reduced [28].
Normally, inflammation is a balanced process; the pro-
duction of anti-inflammatory factors is crucial in limiting
the response to the site of pathological challenge. Expres-
sion levels of LILRB2 and LILRB4 were previously shown
to correlate with inhibitory activity and are enhanced in
the presence of anti-inflammatory agents [4,20,29,30].
Our finding that LILRB2 and LILRB4 are upregulated in
response to Salmonella stimulation indicates that these
receptors play a role in limiting the inflammatory
response during infection.
Conclusion
Our results indicate that the inhibitory effects of LILRB4
do not result from a failure to upregulate co-stimulatory
proteins. In addition to the high level expression that can
render antigen presenting cells tolerogenic, there may be
a role for lower level expression and activity of LILRB2 and
LILRB4 in response to TLR signalling during an immune
response to bacterial infection. The differing roles of
LILRB2 and LILRB4 on antigen presenting cell biology
and in T cell/antigen presenting cell interactions warrant
future studies that should prove useful in multiple fields
of immunology and infectious disease.
LPS treatment upregulates expression of LILRB2 and LILRB4 at a similar level to that observed for whole bacteriaFigu  5
LPS treatment upregulates expression of LILRB2 and LILRB4 at a similar level to that observed for whole bac-
teria. Alterations in the mRNA expression of LILRB4 and LILRB2 in monocyte-derived macrophages following stimulation with 
S. typhimurium LPS, Flagellin, or whole S. typhimurium (either live or heat-killed (H.K.)).Page 6 of 9
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Flow Cytometry
All staining procedures were performed at 4°C. Washed
cells were incubated with a selection from the following
antibodies; CD1a-FITC (BD Pharmingen), CD11c-
Alexafluor647 (Serotec), CD83-FITC (BD Pharmingen),
CD80-PE (BD Pharmingen), CD86-Cychrome (BD
Pharmingen), the unconjugated LILRB4-specific antibody
ZM3.8 [5] was a generous gift from Prof. M. Colonna
(Washington University, USA), LILRB2-PE (Beckman
Coulter), LILRB4-PE (Beckman Coulter), Isotype control
mIgG1 (Southern Biotech), Isotype control antibodies for
flow cytometry (BD Pharmingen). Flow cytometric analy-
sis was performed on a Becton Dickinson FACScan using
CellQuest software.
Culture of in vitro-derived macrophages and dendritic 
cells
Peripheral blood mononuclear cells were obtained from
the National Blood Service (Cambridge, UK; St George's
Hospital, UK) in the form of buffy coat and separated by
density centrifugation over lymphoprep (Axis Shield,
Norway). Adherent cells were cultured in RPMI1640 con-
taining 1% autologous plasma, 50 U/ml penicillin and 50
U/ml streptomycin. Dendritic cells were cultured in 50
ng/ml of GM-CSF and IL-4 (Peprotech), macrophages in
50 ng/ml M-CSF, with cytokines and culture medium
refreshed every second day. Cells were matured on day 6
of culture with 10 ng/ml LPS or as required (see below).
For LILRB4 ligation, dendritic cells were cultured with 10
μg/ml of the LILRB4 specific antibody ZM3.8 or mouse
IgG1 isotype control with 2 μg/ml protein G (Zymed
USA) as a cross-linking agent, ZM3.8/IgG1 isotype and
protein G were refreshed every second day throughout
culture.
For Toll-like Receptor stimulation studies, cells cultured as
above were stimulated on day 6 with 10 ng/ml S. typhimu-
rium LPS (Sigma-Aldrich, UK) or 100 ng/ml S. typhimu-
rium Flagellin (Invivogen, US). Cells were incubated for a
further 24 hours to allow maturation.
Cytokine analysis
An initial screen was performed using a multiplex array
(Bender MedSystems, UK) for IFN-γ, IL-1β, IL-2, IL-4, IL-
5, IL-6, IL-8, IL-10, IL-12p70 and TNF-α according to the
manufacturer's instructions. Commercial quantitative
ELISA kits (R&D systems, UK) were used to assess
cytokine profiles of interest (IL-8, IL-10). The average trip-
licate reading for each standard, control and sample was
subtracted from the average zero standard optical density
reading. A standard curve was determined and used to
determine the total cytokine concentration.
Mixed leukocyte reaction
24 hours after LPS maturation, LILRB4-ligated (and iso-
type control-treated) dendritic cells were washed, irradi-
ated with 50 Gy and added in various dilutions to 96 well
LPS treatment upregulates LILRB2 and LILRB4 on in vitro cultured dendritic cellsFigu  6
LPS treatment upregulates LILRB2 and LILRB4 on in vitro cultured dendritic cells. Flow cytometric analysis was 
used to study surface expression of LILRB4 and LILRB2 on in vitro-cultured dendritic cells following treatment with LPS or flag-
ellin.Page 7 of 9
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cells were negatively isolated using a magnetic bead nega-
tive isolation kit (Dynal, UK) and 5 × 104 cells were added
to triplicate wells containing dendritic cell stimulators.
Culture medium was RPMI1640 with antibiotics, L-
glutamine and 5% human AB serum (Sigma-Aldrich, UK).
On day 6 of culture, 1 μCi of tritiated thymidine (GE
Healthcare, UK) was added and plates incubated for a fur-
ther 18 hours before harvesting and analysis using a scin-
tillation plate reader. Data points were corrected against
readings for negative control wells containing only
responder cells.
Bacterial infection
Salmonella enterica serovar Typhimurium strain 12023
(ATCC 14028) carrying the plasmid pFVP25.1-GFP for
fluorescence visualization [16] was used to infect mono-
cyte-derived macrophages on day 6 of culture. Stationary-
phase Salmonella were opsonised in RPMI containing 20%
human autologous serum for 30 min. Cells were then
washed with PBS and incubated with fresh culture
medium containing gentamicin (50 μg/ml) for 1 hour.
The antibiotic concentration was subsequently reduced to
5 μg/ml for the remainder of the experiment. Salmonella
infection was confirmed by flow cytometric detection of
GFP expression. This procedure was performed in parallel
using S. Typhimurium previously heat-killed by incubation
at 80°C for 10 min.
Real time PCR analysis of LILR expression
RNA was extracted from macrophages 8 hours after TLR
and Salmonella treatments using an RNeasy Kit (Qiagen).
RNA was eluted in 50 μl of 0.2 μm filtered H2O (Sigma).
All samples underwent a DNase treatment using a Turbo
DNase Free kit (Ambion). cDNA synthesis was performed
using Superscript III with an Oligo(dT)20 primer (Invitro-
gen) at 50°C for 1 hour, following the manufacturers
standard protocol. The oligonucleotide sequences used to
assess the expression levels of LILRB2, LILRB4 and the ref-
erence genes GAPDH, YWHAZ and HPRT are given in the
Table 1. Real-time PCR reactions consisted of 10 μl of 2×
QuantiTect SYBR Green solution (Qiagen), 1 ng cDNA,
oligonucleotides and brought to a final volume of 20 μl
with 0.2 μm filtered H2O (sigma). Real-time PCR was per-
formed on an ABI 7500 (PE Applied Biosystems), the
cycling parameters were as follows: 95°C for 15 minutes,
followed by 40 cycles of 94°C for 15 s, 60°C for 30 s and
finally 72°C for 33 s. The fluorescence levels of both SYBR
Green and the internal passive dye ROX were acquired
during the final step. Average cycle threshold (CT) values
were produced using the ABI 7500 System SDS software.
The relative expression level of each target transcript in
differentiating DCs was assessed using qBase [31] by nor-
malisation against all three reference genes.
Abbreviations
ILT: Immunoglobulin like transcript; LILR: Leukocyte Ig-
like receptor; LPS: lipopolysaccharide; MLR: mixed leuko-
cyte reaction; TLR: toll like receptor.
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